Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67
- 1 August 1997
- journal article
- Published by Elsevier in Human Pathology
- Vol. 28 (8) , 974-979
- https://doi.org/10.1016/s0046-8177(97)90014-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prognostic classification of breast ductal carcinoma-in-situThe Lancet, 1995
- Ductal carcinoma in situ of the breast with apocrine cytology: Definition of a borderline categoryHuman Pathology, 1994
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- Noninvasive ductal carcinoma of the breast: The relevance of histologic categorizationHuman Pathology, 1993
- Ductal Carcinoma In Situ of the Female BreastThe American Journal of Surgical Pathology, 1992
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- Duct Carcinoma in Situ: Pathology and TreatmentSurgical Clinics of North America, 1990
- Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrenceCancer, 1989
- Heterogeneity of intraductai carcinoma of the breastCancer, 1989
- Duct carcinoma in situ . Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short‐term treatment failuresCancer, 1982